Asia Pacific Cell Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Cell Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Cell Therapy Market Regional Analysis

6.2 Asia Pacific Cell Therapy Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Cell Therapy Market Forecast Analysis

7. Asia Pacific Cell Therapy Market Analysis – by Therapy Type

7.1 Allogeneic and Autologous

7.1.1 Overview
7.1.2 Allogeneic and Autologous: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Asia Pacific Cell Therapy Market Analysis – by Product

8.1 Consumables

8.1.1 Overview
8.1.2 Consumables: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Systems and Software

8.3.1 Overview
8.3.2 Systems and Software: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Asia Pacific Cell Therapy Market Analysis – by Technology

9.1 Viral Vector Technology

9.1.1 Overview
9.1.2 Viral Vector Technology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Genome Editing Technology

9.2.1 Overview
9.2.2 Genome Editing Technology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Somatic Cell Technology

9.3.1 Overview
9.3.2 Somatic Cell Technology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.4 Cell Immortalization Technology

9.4.1 Overview
9.4.2 Cell Immortalization Technology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.5 Cell Plasticity Technology

9.5.1 Overview
9.5.2 Cell Plasticity Technology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.6 Three-Dimensional Technology

9.6.1 Overview
9.6.2 Three-Dimensional Technology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Asia Pacific Cell Therapy Market Analysis – by Application

10.1 Oncology

10.1.1 Overview
10.1.2 Oncology: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.2 Cardiovascular

10.2.1 Overview
10.2.2 Cardiovascular: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.3 Orthopedic

10.3.1 Overview
10.3.2 Orthopedic: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.4 Wound Management

10.4.1 Overview
10.4.2 Wound Management: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.5 Other Applications

10.5.1 Overview
10.5.2 Other Applications: Asia Pacific Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. Asia Pacific Cell Therapy Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Cell Therapy Market Breakdown, by Key Country, 2020 and 2027 (%)
11.2.1.1 Asia Pacific Cell Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 China: Asia Pacific Cell Therapy Market Breakdown, by Therapy Type
11.2.1.1.2 China: Asia Pacific Cell Therapy Market Breakdown, by Product
11.2.1.1.3 China: Asia Pacific Cell Therapy Market Breakdown, by Technology
11.2.1.1.4 China: Asia Pacific Cell Therapy Market Breakdown, by Application

11.2.1.2 India: Asia Pacific Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 India: Asia Pacific Cell Therapy Market Breakdown, by Therapy Type
11.2.1.2.2 India: Asia Pacific Cell Therapy Market Breakdown, by Product
11.2.1.2.3 India: Asia Pacific Cell Therapy Market Breakdown, by Technology
11.2.1.2.4 India: Asia Pacific Cell Therapy Market Breakdown, by Application

11.2.1.3 Japan: Asia Pacific Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Cell Therapy Market Breakdown, by Therapy Type
11.2.1.3.2 Japan: Asia Pacific Cell Therapy Market Breakdown, by Product
11.2.1.3.3 Japan: Asia Pacific Cell Therapy Market Breakdown, by Technology
11.2.1.3.4 Japan: Asia Pacific Cell Therapy Market Breakdown, by Application

11.2.1.4 Australia: Asia Pacific Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Cell Therapy Market Breakdown, by Therapy Type
11.2.1.4.2 Australia: Asia Pacific Cell Therapy Market Breakdown, by Product
11.2.1.4.3 Australia: Asia Pacific Cell Therapy Market Breakdown, by Technology
11.2.1.4.4 Australia: Asia Pacific Cell Therapy Market Breakdown, by Application

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Cell Therapy Market Breakdown, by Therapy Type
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Cell Therapy Market Breakdown, by Product
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Cell Therapy Market Breakdown, by Technology
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Cell Therapy Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Vericel Corporation

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 MEDIPOST

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 NuVasive, Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Mesoblast Limited

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 JCR Pharmaceuticals Co. Ltd.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Smith & Nephew

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Bristol-Myers Squibb Company

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Cells for Cells

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Stemedica Cell Technologies, Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Castle Creek Biosciences, Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Cell Therapy Market